Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey
Nigeria, 2014 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
78148
Downloads
510
BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug9)
Data file: pmv_release
Overview
Valid:
13
Invalid:
0
Type:
Discrete
Start:
5710
End:
5754
Width:
45
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| Amatem Forte | 1 |
7.7%
|
|
| Amatem Forte ( Artemether lumefantrine ) | 1 |
7.7%
|
|
| Artemether and Lumefantrine ( Act ) | 1 |
7.7%
|
|
| BG-MAL | 1 |
7.7%
|
|
| Gilanox(S.P) | 1 |
7.7%
|
|
| Gvither Plus ( Artemether and Lumefantrine ) | 1 |
7.7%
|
|
| Lokmal - QS ( Artemether and Lumefantrine ) | 1 |
7.7%
|
|
| Lokmal - QS ( Artemether and Lumefantrine) | 1 |
7.7%
|
|
| Lonart-DS | 1 |
7.7%
|
|
| Lonart-DS ( Artemether and Lumefantrine ) | 1 |
7.7%
|
|
| Lumartem ACT | 1 |
7.7%
|
|
| Melofan ( sp ) | 1 |
7.7%
|
|
| P-Alaxin ( Dihydroartemisin and piperaquine ) | 1 |
7.7%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.